Table of Contents
Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In order to treat the life-threatening disease more efficiently and with enhanced specificity, monoclonal antibodies have become the most widely used cancer therapy. As per the findings of our new research report, cancer monoclonal antibodies provide hi...More »
The Largest Collection of Market Research Reports
From +200,000 authoritative sources
Talk to Jordan
+1 917 267 7886
World demand to increase 6.4% annually through 2017 World enzyme demand is forecast to rise 6.4 percent per annum to $6.9 billion in 2017. Increasing per capita incomes in developing countries will help ...
Biosimilar Index answers your questions, such as... - There are 15 biosimilar and non-comparable biologic (NCB) versions of bevacizumab (Avastin; Roche) in clinical development; with the Biosimilar Index ...
Membrane technology is widely used in various development phases of pharmaceutical, biopharmaceutical and life sciences industries. Membrane technology includes membrane applications from laboratory drug ...
... As a cand to be used in a subunit vaccine against swine erysipelas (imada et al. 1999; Kitajima et al. 2000), Replacing the cellular vaccines in use. The production of recombinant antigenic proteins ...
... Konstantinov kb, yoshida t: dielectric measurement to monitor the growth and the physiological states of biological cells. bioprocess engineering 1994, 11:213 222. 40. Luli gw, strohl wr: comparison of growth ...
Reportlinker.com © Copyright 2014. All rights reserved.